RU2000111645A - METHOD FOR TREATING HEMORRHAGIC FEVER WITH RENAL SYNDROME - Google Patents

METHOD FOR TREATING HEMORRHAGIC FEVER WITH RENAL SYNDROME

Info

Publication number
RU2000111645A
RU2000111645A RU2000111645/14A RU2000111645A RU2000111645A RU 2000111645 A RU2000111645 A RU 2000111645A RU 2000111645/14 A RU2000111645/14 A RU 2000111645/14A RU 2000111645 A RU2000111645 A RU 2000111645A RU 2000111645 A RU2000111645 A RU 2000111645A
Authority
RU
Russia
Prior art keywords
hemorrhagic fever
renal syndrome
treating hemorrhagic
treating
days
Prior art date
Application number
RU2000111645/14A
Other languages
Russian (ru)
Other versions
RU2181046C2 (en
Inventor
Гульнара Рафисовна Абдулова
Евгений Константинович Алехин
Дина Халиловна Хунафина
Альберт Самойлович Саратиков
Расима Тимерьяновна Мурзабаева
Дамир Асхатович Валишин
Валерий Борисович Егоров
Самара Саяфовна Хасанова
Original Assignee
Башкирский государственный медицинский университет
Filing date
Publication date
Application filed by Башкирский государственный медицинский университет filed Critical Башкирский государственный медицинский университет
Priority to RU2000111645A priority Critical patent/RU2181046C2/en
Priority claimed from RU2000111645A external-priority patent/RU2181046C2/en
Publication of RU2000111645A publication Critical patent/RU2000111645A/en
Application granted granted Critical
Publication of RU2181046C2 publication Critical patent/RU2181046C2/en

Links

Claims (1)

Способ лечения ГЛПС иммунокорригирующим препаратом на фоне общепринятой терапии, отличающийся тем, что больному вводят йодантипирин в течение 9 дней, при этом в первые 4 дня в суточной дозе 0,6 г, в последующие - в дозе 0,3 г.A method of treating HFRS with an immunocorrective drug against the background of conventional therapy, characterized in that the patient is administered iodantipyrine for 9 days, with a daily dose of 0.6 g in the first 4 days, and a dose of 0.3 g in the following days.
RU2000111645A 2000-05-10 2000-05-10 Method to treat hemorrhagic fever at renal syndrome RU2181046C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2000111645A RU2181046C2 (en) 2000-05-10 2000-05-10 Method to treat hemorrhagic fever at renal syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2000111645A RU2181046C2 (en) 2000-05-10 2000-05-10 Method to treat hemorrhagic fever at renal syndrome

Publications (2)

Publication Number Publication Date
RU2000111645A true RU2000111645A (en) 2002-02-27
RU2181046C2 RU2181046C2 (en) 2002-04-10

Family

ID=20234416

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000111645A RU2181046C2 (en) 2000-05-10 2000-05-10 Method to treat hemorrhagic fever at renal syndrome

Country Status (1)

Country Link
RU (1) RU2181046C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008123590A (en) * 2008-06-17 2009-12-27 Владимир Николаевич Худолей (RU) MEANS WITH MEMBRANO-STABILIZING EFFECT

Similar Documents

Publication Publication Date Title
NO20053105D0 (en) Oral, extended-release analgesic dosage form for administration ± once per day. day.
CY1105707T1 (en) COMBINATIONS OF FORMOTEROL AND A TRIOTROP SALT
EE9700192A (en) Oral pharmaceutical dosage form comprising a proton pump inhibitor and an antacid or alginate
JP2001515712A5 (en)
TR200002786T2 (en) A new galenic formulation for meloxicam.
MX9604354A (en) New oral pharmaceutical dosage form.
EE200000503A (en) Method for the preparation of a pharmaceutical composition of topiramate, a pharmaceutical composition and the use of topiramate in the manufacture of a medicament for the treatment of diabetes
CO4290346A1 (en) Azithromycin Controlled Release Dosage Forms
EA200101156A1 (en) DRUG COMPOSITIONS OF A NEW TYPE ON THE BASIS OF POSSESSING HOLYNTHERGIC ACTION OF COMPOUNDS AND β-MIMETIC
TNSN94035A1 (en) VETERINARY COMPOSITION
ATE211907T1 (en) OSMOTIC DRUG RELEASE SYSTEM
ATE165000T1 (en) DOSAGE FORM FOR DELAYED RELEASE
NO20032027L (en) Effective anti-tumor treatments
EE04606B1 (en) Use of H +, K + -ATPase Inhibitor in the manufacture of a medicament for oral administration
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
HUP9700806A2 (en) Matrix tablet allowing the prolonged release of the sodium salt of tianeptine and process for the preparation thereof
NO306718B1 (en) New compounds with analgesic and local anesthetic effect, pharmaceutical preparations containing these compounds and their use
SE9902597D0 (en) New use
RU2002103808A (en) METHOD FOR TREATING PAIN SYNDROME IN ONCOLOGIC PATIENTS
TR199801184T2 (en) New compounds with analgesic action.
RU2000111645A (en) METHOD FOR TREATING HEMORRHAGIC FEVER WITH RENAL SYNDROME
EE03205B1 (en) Use of ropivacaine in the manufacture of a medicament for use as an analgesic
RU2004112422A (en) ROUVASTATIN IN PREDEDENTIONAL CONDITIONS
KR960003718A (en) Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases
SE9904424D0 (en) Use of interleukin-6 in combination with leptin in the treatment of obesity